Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 18, 2024Journal of Clinical MedicineOpen Access

Contemporary Use of Sodium Glucose Co-Transporter 2 Inhibitors in Hospitalized Heart Failure Patients: A “Real-World” Experience

View Full Paper
Ask AI
Bookmark
Share

Authors

ΑXΑndrew XanthopoulosΝΚΝικόλαος ΚατσιάδαςGGGrigorios Giamouzis

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xanthopoulos et al. (2024) studied this question.

synapsesocial.com/papers/68e6452bb6db6435875d651chttps://doi.org/10.3390/jcm13123562
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sodium-Glucose Co-Transporter 2 Inhibitors in Acute Heart Failure: Real-World Prescription Trends and Outcomes Analysis2023 · 21 citations
  2. 2Clinical Effectiveness of Sodium‐Glucose Cotransporter‐2 Inhibitors Among Older Patients Hospitalized for Heart Failure With Reduced Ejection Fraction2026 · 1 citations
  3. 3Sodium-Glucose Cotransporter Type 2 Inhibitors Use in Elderly Polypathological Patients with Acute Heart Failure: PROFUND-IC Registry2024 · 4 citations
  4. 4Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: An Updated Meta-Analysis2022 · 20 citations
  5. 5Determinants and Prognostic Impact of In-Hospital Sodium-Glucose Cotransporter-2 Inhibitor Initiation in Patients with Heart Failure2026